Altimmune, Inc. (ALT)
NASDAQ: ALT · Real-Time Price · USD
3.780
+0.220 (6.18%)
At close: Sep 5, 2025, 4:00 PM
3.730
-0.050 (-1.32%)
After-hours: Sep 5, 2025, 7:41 PM EDT
Altimmune Employees
Altimmune had 59 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
59
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$339
Profits / Employee
-$1,487,220
Market Cap
333.61M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 59 | 0 | - |
Dec 31, 2023 | 59 | 7 | 13.46% |
Dec 31, 2022 | 52 | 5 | 10.64% |
Dec 31, 2021 | 47 | 4 | 9.30% |
Dec 31, 2020 | 43 | 18 | 72.00% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ALT News
- 1 day ago - INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune - PRNewsWire
- 10 days ago - SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune - GlobeNewsWire
- 11 days ago - Altimmune: Is There Still Hope For Pemvidutide? I Believe There Is (Upgrade) - Seeking Alpha
- 12 days ago - Altimmune to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 19 days ago - Altimmune Announces FDA Fast Track Designation for Pemvidutide in Alcohol Use Disorder (AUD) - GlobeNewsWire
- 20 days ago - The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of October 6, 2025 in Altimmune, Inc. Lawsuit - ALT - PRNewsWire
- 23 days ago - Berger Montague PC Investigates Securities Claims Against Altimmune, Inc. (NASDAQ: ALT) - PRNewsWire
- 25 days ago - Altimmune, Inc. (ALT) Q2 2025 Earnings Call Transcript - Seeking Alpha